Feasibility of tacrolimus, methotrexate, and prednisolone as a graft-versus-host disease prophylaxis in non-T-cell-depleted haploidentical hematopoietic stem cell transplantation for children. [electronic resource]
Producer: 20120522Description: 892-7 p. digitalISSN:- 1399-0012
- Adolescent
- Adult
- Anti-Inflammatory Agents -- therapeutic use
- Child
- Child, Preschool
- Feasibility Studies
- Female
- Follow-Up Studies
- Graft vs Host Disease -- epidemiology
- Hematologic Neoplasms -- immunology
- Hematopoietic Stem Cell Transplantation -- adverse effects
- Histocompatibility
- Humans
- Immunosuppressive Agents -- therapeutic use
- Incidence
- Infant
- Infant, Newborn
- Japan -- epidemiology
- Male
- Methotrexate -- therapeutic use
- Prednisolone -- therapeutic use
- Prognosis
- Survival Rate
- T-Lymphocytes -- immunology
- Tacrolimus -- therapeutic use
- Transplantation, Homologous
- Young Adult
No physical items for this record
Publication Type: Journal Article
There are no comments on this title.
Log in to your account to post a comment.